Blocking the GDF15/GFRAL pathway genetically or pharmacologically has demonstrated robust effects in mitigating anorexia and weight loss induced by tumor and/or cisplatin in preclinical models [9,11,22,23]. Here, GDF15 is linked to Anorexia.